Metformin directly suppresses atherosclerosis in normoglycaemic mice via haematopoietic adenosine monophosphate-activated protein kinase
ConclusionMetformin activates a conserved AMPK-ATF1-M2-like pathway in mouse and human macrophages, and results in highly suppressed atherogenesis in hyperlipidaemic mice via haematopoietic AMPK.
Source: Cardiovascular Research - Category: Cardiology Source Type: research
More News: Bone Marrow Transplant | Cardiology | Cardiovascular | Fortamet | Genetics | Heart | Metformin | Transplants